Finding cases of dementia and mild cognitive impairment in Pavia
OPENING OF A MEMORY CLINIC IN THE PROVINCE OF PAVIA: Evaluation of Case-finding Strategies and Care for People With Cognitive Decline and Their Caregivers.
This study is trying to find new cases of dementia and mild cognitive impairment in Pavia to improve care and support for patients and their families.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 490 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS National Neurological Institute "C. Mondino" Foundation Academic / other |
| Locations | 1 site (Pavia, Pavia) |
| Trial ID | NCT06983119 on ClinicalTrials.gov |
What this trial studies
This project aims to tackle the global public health challenge of dementia by focusing on early detection and comprehensive care. It evaluates the effectiveness of case-finding strategies through the 'Ricor-Dare' project, which seeks to create an integrated network for identifying new cases of dementia or Mild Cognitive Impairment (MCI) and providing necessary support to patients and caregivers. Additionally, it involves establishing a new Center for Cognitive Disorders and Dementia in an area lacking such services, thereby enhancing the healthcare response to cognitive decline.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 50 or older who have not been previously diagnosed with cognitive decline.
Not a fit: Patients under the age of 50 or those already diagnosed with cognitive decline may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could lead to earlier diagnoses and better management of dementia and MCI, improving the quality of life for patients and their caregivers.
How similar studies have performed: Other studies focusing on early detection and integrated care for dementia have shown promise, indicating that this approach could be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
For the Primary Outcome the inclusion criteria are: * Age 50 or older * Assessment conducted using GPcog/ACE-III depending on the setting * No prior diagnosis of cognitive decline * Ability to understand the study objectives and sign an informed consent For the Primary Outcome the exclusion criteria are: * Age under 50 * Presence of a diagnosis of cognitive decline * Limited knowledge of the Italian language For the secondary outcome the inclusion criteria are: Patient: * All patients/people who are included in one of the actions provided through the "Ricor-Dare" Project or who are attending a visit scheduled in the clinical-care pathway of the CDCD Fondazione Mondino Pavia or Lomellina; * Ability to understand the aims of the study and to sign an informed consent Caregiver: * Age equal to or greater than 18 years * Informal caregiver of a family member with a suspected or confirmed diagnosis of dementia who is included in one of the actions provided through the "Ricor-Dare" project or who are attending a visit scheduled in the clinical-care pathway of the CDCD; * Acceptance of informed consent and voluntary participation in the study. Healthcare professionals: * All healthcare and social healthcare professionals (GPs, pharmacists, nurses, nurses auxiliary) who practice in the cities of Pavia and Vigevano who participate in the project and agree to undergo assessments and training; * Acceptance of informed consent and voluntary participation in the study. Fo the Secondary Outcome the exclusion criteria are: Patient: \- Inability to understand the aims of the study and to sign an informed consent Caregiver: * Age under 18 * Formal caregivers, i.e. any person who provides assistance to the patient in exchange for payment of a fee; * Caregivers with limited knowledge of the Italian language.
Where this trial is running
Pavia, Pavia
- IRCCS National Neurological Institute "C. Mondino" Foundation — Pavia, Pavia, Italy (Recruiting)
Study contacts
- Study coordinator: Nicola Allegri, PhD
- Email: nicola.allegri@mondino.it
- Phone: 0039 0381692413
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.